197 related articles for article (PubMed ID: 16487958)
1. Environmental arsenic exposure and sputum metalloproteinase concentrations.
Josyula AB; Poplin GS; Kurzius-Spencer M; McClellen HE; Kopplin MJ; Stürup S; Clark Lantz R; Burgess JL
Environ Res; 2006 Nov; 102(3):283-90. PubMed ID: 16487958
[TBL] [Abstract][Full Text] [Related]
2. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
3. Environmental Arsenic Exposure and Urinary 8-OHdG in Arizona and Sonora.
Burgess JL; Meza MM; Josyula AB; Poplin GS; Kopplin MJ; McClellen HE; Stürup S; Lantz RC
Clin Toxicol (Phila); 2007; 45(5):490-8. PubMed ID: 17503254
[TBL] [Abstract][Full Text] [Related]
4. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma.
Tanaka H; Miyazaki N; Oashi K; Tanaka S; Ohmichi M; Abe S
J Allergy Clin Immunol; 2000 May; 105(5):900-5. PubMed ID: 10808169
[TBL] [Abstract][Full Text] [Related]
5. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico.
Meza MM; Kopplin MJ; Burgess JL; Gandolfi AJ
Environ Res; 2004 Oct; 96(2):119-26. PubMed ID: 15325872
[TBL] [Abstract][Full Text] [Related]
6. Clinical study of inflammatory factors in sputum induced early after lung volume reduction surgery.
Miao JB; Hou SC; Li H; Hu B; Wang TY
Chin Med J (Engl); 2008 Sep; 121(18):1796-9. PubMed ID: 19080360
[TBL] [Abstract][Full Text] [Related]
7. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
8. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
9. Reduction in urinary arsenic with bottled-water intervention.
Josyula AB; McClellen H; Hysong TA; Kurzius-Spencer M; Poplin GS; Stürup S; Burgess JL
J Health Popul Nutr; 2006 Sep; 24(3):298-304. PubMed ID: 17366771
[TBL] [Abstract][Full Text] [Related]
10. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
Calikoğlu M; Unlü A; Tamer L; Ozgür E
Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566
[TBL] [Abstract][Full Text] [Related]
11. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
Mercer PF; Shute JK; Bhowmik A; Donaldson GC; Wedzicha JA; Warner JA
Respir Res; 2005 Dec; 6(1):151. PubMed ID: 16372907
[TBL] [Abstract][Full Text] [Related]
12. Arsenic exposure in multiple environmental media in children near a smelter.
Morse DL; Harrington JM; Housworth J; Landrigan PJ; Kelter A
Clin Toxicol; 1979 Apr; 14(4):389-99. PubMed ID: 466981
[TBL] [Abstract][Full Text] [Related]
13. [Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma].
Klisho EV; Savenkova OV; Kondakova IV; Perel'muter VM; Choĭnzonov EL; Shishkin DA
Vopr Onkol; 2007; 53(1):26-31. PubMed ID: 17649730
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
Määtta M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Santala M
Anticancer Res; 2007; 27(4C):2753-8. PubMed ID: 17695443
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for increased urinary inorganic arsenic concentrations from low arsenic concentrations in drinking water.
Hinwood AL; Sim MR; Jolley D; de Klerk N; Bastone EB; Gerostamoulos J; Drummer OH
Int J Environ Health Res; 2003 Sep; 13(3):271-84. PubMed ID: 12909558
[TBL] [Abstract][Full Text] [Related]
16. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA.
Slotnick MJ; Meliker JR; Nriagu JO
J Expo Sci Environ Epidemiol; 2008 Mar; 18(2):149-57. PubMed ID: 17426735
[TBL] [Abstract][Full Text] [Related]
17. Unexpected smoking-linked high MMP-9 in induced sputum of hazardous dust-exposed workers.
Lerman Y; Moscovich A; Fireman E
Mediators Inflamm; 2006; 2006(3):24827. PubMed ID: 16951487
[TBL] [Abstract][Full Text] [Related]
18. House dust and inorganic urinary arsenic in two Arizona mining towns.
Hysong TA; Burgess JL; Cebrián Garcia ME; O'Rourke MK
J Expo Anal Environ Epidemiol; 2003 May; 13(3):211-8. PubMed ID: 12743615
[TBL] [Abstract][Full Text] [Related]
19. Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population.
Caceres DD; Pino P; Montesinos N; Atalah E; Amigo H; Loomis D
Environ Res; 2005 Jun; 98(2):151-9. PubMed ID: 15820720
[TBL] [Abstract][Full Text] [Related]
20. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
Vignola AM; Riccobono L; Profita M; Foresi A; Di Giorgi R; Guerrera D; Gjomarkaj M; Di Blasi P; Paggiaro PL
Allergy; 2005 Dec; 60(12):1511-7. PubMed ID: 16266383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
